Corvus Pharmaceuticals, Inc. (CRVS) Technical Analysis

🔺 Technical Setup

🎯 Decision Map

The next meaningful technical decision is likely to occur between support at 11.64 and resistance at 15.40. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.

📊 Technical Summary

Corvus Pharmaceuticals, Inc. (CRVS) finished the session at 15.19 (+5.34%). Price has slipped under the 50-day average but remains above the 200-day average, leaving the longer-term structure intact even as medium-term momentum softens. 20-day momentum is positive at +5.27%; price remains inside its roughly 52-week range (3.20–25.52); and ATR14 volatility is elevated at roughly 8.76% of price. RSI(14) stands around 48.0, which keeps the momentum picture broadly balanced. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD is positioned under the signal line, suggesting momentum recovery has not fully developed yet. The MACD histogram is negative and weakening further, which reflects continued downside pressure. The most important nearby levels are support at 11.64 and resistance at 15.40. Clearing resistance would improve continuation odds, while slipping below support would weaken the present setup. On the fundamentals side, the latest snapshot shows Net income: -15.30M · EPS (basic): -0.12. For a fuller technical read, the interactive view adds overlays, pattern context and broader chart structure.

Explore more